Chester County News and Community Website
WASHINGTON, D.C. — The U.S. Food and Drug Administration states it recently amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine, authorizing the use of a single booster …
FDA Expands Eligibility for Pfizer-BioNTech COVID-19 Vaccine Booster Dose to Children 5 through 11 Years Read More
WASHINGTON, D.C. — The U.S. Department of Health and Human Services (HHS), through the Health Resources and Services Administration (HRSA), is providing $66.5 million in American Rescue Plan funding to …
$66.5 Million Announced to Expand Community-Based Outreach Efforts to Increase COVID-19 Vaccinations Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced a virtual meeting of its Vaccines and Related Biological Products Advisory Committee (VRBPAC) on Feb. 15 to discuss the request for …
FDA Advisory Committee Meeting to Discuss Authorization of Pfizer-BioNTech COVID-19 Vaccine for Children 6 Months Through 4 Years of Age Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration has taken two actions to expand the use of the antiviral drug Veklury (remdesivir) to certain non-hospitalized adults and pediatric patients …
FDA Takes Actions to Expand Use of Treatment for Outpatients with Mild-to-Moderate COVID-19 Read More
WASHINGTON, D.C. — On Tuesday, CDC updated its recommendation for when many people can receive a booster shot, shortening the interval from 6 months to 5 months for people who …
CDC Recommends Pfizer Booster at 5 Months, Additional Primary Dose for Certain Immunocompromised Children Read More
WASHINGTON, D.C. — The U.S. Food and Drug Administration announced that this week it has amended the emergency use authorization (EUA) for the Pfizer-BioNTech COVID-19 Vaccine to:
FDA Takes Multiple Actions to Expand Use of Pfizer-BioNTech COVID-19 Vaccine Read More
WASHINGTON, D.C. — The Office for Civil Rights (OCR) at the U.S. Department of Health and Human Services (HHS) issued guidance tied to legal standards and best practices for improving …
New Guidance to Boost Accessibility and Equity in COVID-19 Vaccine Programs Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention announced that it is shortening the recommended time for isolation from 10 days for people with COVID-19 to 5 days, …
CDC Updates and Shortens Recommended Isolation and Quarantine Period for General Population Read More
WASHINGTON, D.C. — With the growing number of COVID-19 cases from the Omicron variant, and consistent with current understanding of the disease trajectory, CDC released updated guidance for isolation and …
CDC Releases Emergency Guidance for Healthcare Facilities to Prepare for Potential Omicron Surge Read More
WASHINGTON, D.C. — The Centers for Disease Control and Prevention released two reports recently in the Morbidity and Mortality Weekly Report highlighting the use of test-to-stay practices used in schools to …
Test-To-Stay Options Can Help Keep Students in School During COVID-19, Says CDC Read More